Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bayer Ag Ord
(OP:
BAYZF
)
30.89
-0.05 (-0.15%)
Streaming Delayed Price
Updated: 11:16 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,668
Open
30.70
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
30.94
Today's Range
30.70 - 30.89
52wk Range
26.91 - 57.58
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Futures Rally Fizzles As Dollar, Yields And Oil Slump
August 17, 2024
US equity futures erased earlier gains and were trading with modest losses as the dollar, oil, and yields all slumped entering the US session.
Via
Talk Markets
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
July 25, 2024
Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Glyphosate
Legal
Performance
YTD
-18.19%
-18.19%
1 Month
+4.26%
+4.26%
3 Month
-0.28%
-0.28%
6 Month
+1.29%
+1.29%
1 Year
-42.82%
-42.82%
More News
Read More
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
June 05, 2024
Via
Benzinga
Exposures
Glyphosate
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Via
Benzinga
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
May 02, 2024
Via
Benzinga
Exposures
Glyphosate
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
March 19, 2024
Via
Benzinga
Exposures
Product Safety
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Glyphosate
Legal
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
March 05, 2024
Via
Benzinga
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
Via
Benzinga
Exposures
Product Safety
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
January 30, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Glyphosate
Legal
Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
January 29, 2024
Via
Benzinga
Exposures
Glyphosate
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
Via
Benzinga
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
January 08, 2024
Via
Benzinga
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
January 04, 2024
Via
Benzinga
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
December 26, 2023
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Glyphosate
Legal
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
December 19, 2023
Via
Benzinga
Topics
Climate Change
Exposures
Climate
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
December 06, 2023
Via
Benzinga
Exposures
Glyphosate
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
December 04, 2023
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Glyphosate
Legal
German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
November 24, 2023
Via
Benzinga
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
November 20, 2023
Via
Benzinga
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
November 20, 2023
Via
Benzinga
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
November 17, 2023
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
November 08, 2023
Via
Benzinga
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
November 01, 2023
Via
Benzinga
Exposures
Glyphosate
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.